A.-E. Roske

1.7k total citations
16 papers, 1.5k citations indexed

About

A.-E. Roske is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, A.-E. Roske has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in A.-E. Roske's work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). A.-E. Roske is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). A.-E. Roske collaborates with scholars based in Germany, Switzerland and Denmark. A.-E. Roske's co-authors include Carsten Denkert, Manfred Dietel, Wilko Weichert, Thomas Beckers, Volker Gekeler, Silvia Niesporek, Aurelia Noske, Ann‐Christin Buckendahl, Klaus Jung and Glen Kristiansen and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

A.-E. Roske

16 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.-E. Roske Germany 8 1.3k 445 175 149 85 16 1.5k
Lauren M. Thorpe United States 5 862 0.7× 341 0.8× 201 1.1× 196 1.3× 141 1.7× 7 1.2k
Sandaruwan Geeganage United States 11 626 0.5× 361 0.8× 195 1.1× 179 1.2× 86 1.0× 21 1.0k
Rumey C. Ishizawar United States 8 600 0.5× 436 1.0× 111 0.6× 170 1.1× 83 1.0× 13 1.1k
Ann‐Christin Buckendahl Germany 12 747 0.6× 307 0.7× 191 1.1× 91 0.6× 108 1.3× 14 970
Maryland Rosenfeld-Franklin United States 8 681 0.5× 364 0.8× 272 1.6× 160 1.1× 70 0.8× 13 1.0k
Toshiyuki Isoe Japan 16 623 0.5× 385 0.9× 110 0.6× 145 1.0× 58 0.7× 30 935
Wenwen Chien United States 20 822 0.6× 250 0.6× 212 1.2× 104 0.7× 62 0.7× 29 1.1k
Arthur Groy United States 6 497 0.4× 279 0.6× 78 0.4× 122 0.8× 109 1.3× 7 696
Julie C. Lougheed United States 12 571 0.4× 259 0.6× 109 0.6× 168 1.1× 108 1.3× 16 998
Yuqian Yan United States 19 1.0k 0.8× 392 0.9× 278 1.6× 315 2.1× 72 0.8× 37 1.4k

Countries citing papers authored by A.-E. Roske

Since Specialization
Citations

This map shows the geographic impact of A.-E. Roske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-E. Roske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-E. Roske more than expected).

Fields of papers citing papers by A.-E. Roske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-E. Roske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-E. Roske. The network helps show where A.-E. Roske may publish in the future.

Co-authorship network of co-authors of A.-E. Roske

This figure shows the co-authorship network connecting the top 25 collaborators of A.-E. Roske. A scholar is included among the top collaborators of A.-E. Roske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-E. Roske. A.-E. Roske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Modern Pathology. 22(4). 579–588. 32 indexed citations
2.
Noske, Aurelia, Areeg Faggad, Silvia Darb‐Esfahani, et al.. (2009). IMP3 Expression in Human Ovarian Cancer is Associated With Improved Survival. International Journal of Gynecological Pathology. 28(3). 203–210. 25 indexed citations
3.
Weichert, Wilko, A.-E. Roske, Silvia Niesporek, et al.. (2008). Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo. Clinical Cancer Research. 14(6). 1669–1677. 299 indexed citations
4.
Fritzsche, Florian, Wilko Weichert, A.-E. Roske, et al.. (2008). Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer. 8(1). 381–381. 150 indexed citations
5.
Weichert, Wilko, A.-E. Roske, Volker Gekeler, et al.. (2008). Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. The Lancet Oncology. 9(2). 139–148. 313 indexed citations
6.
Noske, Aurelia, Wilko Weichert, Silvia Niesporek, et al.. (2008). Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer. 112(8). 1733–1743. 177 indexed citations
7.
Darb‐Esfahani, Silvia, Areeg Faggad, Aurelia Noske, et al.. (2008). Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro. Journal of Cancer Research and Clinical Oncology. 135(7). 933–941. 65 indexed citations
8.
Weichert, Wilko, A.-E. Roske, Volker Gekeler, et al.. (2008). Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. British Journal of Cancer. 98(3). 604–610. 395 indexed citations
9.
Ebert, Martin A., Wilko Weichert, A.-E. Roske, et al.. (2008). Class I HDAC expression patterns are highly prognostic in human gastric cancer. Journal of Clinical Oncology. 26(15_suppl). 11114–11114. 1 indexed citations
10.
Niesporek, Silvia, Wilko Weichert, Bruno V. Sinn, et al.. (2007). [NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].. PubMed. 91. 243–9. 4 indexed citations
11.
12.
Wruck, U., P Romaniuk, A.-E. Roske, et al.. (1998). Estimation of tips blood flow by intravascular and percutaneous ultrasound. Gastroenterology. 114. A1366–A1367. 1 indexed citations
13.
Schütz, T., A.-E. Roske, Andreas Lehmann, Herbert Lochs, & Mathias Plauth. (1998). O.42 Pathogenesis of malnutrition in patients with hepatocellular carcinoma (HCC). Clinical Nutrition. 17. 12–13. 1 indexed citations
14.
Plauth, Mathias, et al.. (1998). Pathogenesis of malnutrition in liver cirrhosis: Role of pro- and antiinflammatory cytokines. Gastroenterology. 114. A901–A901. 1 indexed citations
15.
Roske, A.-E., T. Schütz, Matthias Pirlich, et al.. (1997). O.56 Effect of liver transplantation on substrate utilizationand body composition. Clinical Nutrition. 16. 16–16. 1 indexed citations
16.
Plauth, Mathias, A.-E. Roske, David Stockheim, et al.. (1997). P.45 Small intestinal ammonia production is a majordeterminant of post-feeding hyperammonemia in liver cirrhosis. Clinical Nutrition. 16. 34–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lauren M. Thorpe Breakdown of academic impact, for papers by Sandaruwan Geeganage Breakdown of academic impact, for papers by Rumey C. Ishizawar Breakdown of academic impact, for papers by Ann‐Christin Buckendahl Breakdown of academic impact, for papers by Maryland Rosenfeld-Franklin Breakdown of academic impact, for papers by Toshiyuki Isoe Breakdown of academic impact, for papers by Wenwen Chien Breakdown of academic impact, for papers by Arthur Groy Breakdown of academic impact, for papers by Julie C. Lougheed Breakdown of academic impact, for papers by Yuqian Yan
Rankless by CCL
2026